Innovation, Technology, and IP News

Written by: Alistair J. McIntyre & Jason J. Jardine On September 26, 2023, Nexus Pharmaceuticals, LLC[1] announced[2] that it had... Read More »

Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit... Read More »

Written by: Ari Feinstein & Jane Dai, Ph.D. On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC... Read More »

Written by: Zachary B. Messick & Brenden S. Gingrich, Ph.D. As retailers or distributors that are not manufacturers of a product... Read More »

Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA)... Read More »

Written by: Sophia Petrichenko & Jason J. Jardine As predictions of an economic recession in the United States loom, 2023 has... Read More »

Written by: Alistair J. McIntyre & Jane Dai, Ph.D.   On April 21, 2023, the Supreme Court granted a ... Read More »

By Ariel Soiffer, Elijah Soko and Paul Lekas (January 20, 2023) This article was not written by ChatGPT. Will all articles have to... Read More »

Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought battle ... Read More »

In my first post on the Subcommittee Hearings held last week, I noted the absence of many witnesses from the life science industry, as opposed to groups such as IPO... Read More »

Three years ago, we started publishing the Patexia Insight Series with our first article about the Shortage of Patent Attorneys in the U.S. A lot has changed since... Read More »

Although this list will reach most the readers of Patents4Life after 2019 begins, 2018 deserves some attention even if it has the feel of “those we lost in... Read More »

Written by Jeffrey C. Wu, Ph.D. and Brenden S. Gingrich, Ph.D. New York City took a step toward its goal of becoming a life sciences hub with a $5 million grant... Read More »